Search results for "Bleeding"

showing 10 items of 249 documents

Double-balloon enteroscopy-facilitated cyanoacrylate-injection endotherapy of small-bowel varices: an international experience from 2 European tertia…

2019

Background and Aims Small-bowel varices (SBVs) are an uncommon consequence of portal hypertension. Radiologic intervention is usually considered for first-line management. When radiologic intervention is not possible, management options become very limited. The aim of this study was to evaluate the usefulness of double-balloon enteroscopy (DBE)-facilitated cyanoacrylate-injection endotherapy of SBVs. Methods This was a retrospective review of DBE-facilitated cyanoacrylate-injection endotherapy of SBVs (December 2015 to October 2016). Results Ten DBEs were performed in 6 patients (4 women; median age, 68.5 years). No radiologic or surgical options were deemed feasible. Thirteen nests of SBVs…

EnteroscopyMalemedicine.medical_specialtyInternational Cooperationlaw.inventionInjectionsTertiary Care CentersVaricose Veins03 medical and health sciences0302 clinical medicinelawDouble-balloon enteroscopyIntestine SmallmedicineHumansRadiology Nuclear Medicine and imagingCyanoacrylatesAdverse effectAgedRetrospective StudiesAged 80 and overDouble-Balloon Enteroscopymedicine.diagnostic_testbusiness.industryGastroenterologyRetrospective cohort studyMiddle Agedmedicine.diseaseAcute gi bleedingSurgeryCyanoacrylate030220 oncology & carcinogenesisPortal hypertension030211 gastroenterology & hepatologyFemaleVaricesbusinessGastrointestinal endoscopy
researchProduct

Long-term outcome after argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleedi…

2011

BACKGROUND AND STUDY AIMS Vascular malformations are the most common sources of bleeding in the small bowel. They can be treated with argon plasma coagulation (APC) during double-balloon enteroscopy (DBE). This study aimed to evaluate the long-term follow-up of the effectiveness of APC for small-bowel bleeding by means of a single-center retrospective study. PATIENTS AND METHODS Between June 2003 and December 2005, APC treatment for small-bowel lesions was carried out during DBE in 63 patients with known or suspected mid-gastrointestinal bleeding. Fifty patients were included in the analysis. Main outcome measurements were comparison of hemoglobin values and blood transfusion requirements b…

Enteroscopymedicine.medical_specialtyGastrointestinal bleedingBlood transfusionmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentGastroenterologyRetrospective cohort studyArgon plasma coagulationmedicine.diseaseGastroenterologySurgeryInternal medicineDouble-balloon enteroscopyMedicineIn patientHemoglobinbusinessEndoscopy
researchProduct

Mid-gastrointestinal bleeding: capsule endoscopy and push-and-pull enteroscopy give rise to a new medical term.

2006

Enteroscopymedicine.medical_specialtyGastrointestinal bleedingmedicine.diagnostic_testbusiness.industryGeneral surgeryGastroenterologyMEDLINEmedicine.diseaseEndoscopy Gastrointestinallaw.inventionEndoscopyCapsule endoscopylawTerminology as TopicPush and pullMedicineHumansEndoscopy Digestive SystembusinessGastrointestinal HemorrhageEndoscopy
researchProduct

Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi® ) in the treatment of von Wille…

2002

Summary. The goal of therapy in patients with von Willebrand disease (vWD) is to correct the dual defect of primary haemostasis and intrinsic coagulation reflected by low levels of von Willebrand factor (vWF) and factor VIII coagulant activity (FVIII:C). Factor VIII/von Willebrand factor (FVIII/vWF) concentrates are currently the treatment of choice in vWD patients unresponsive to desmopressin (DDAVP). However, only few studies on their clinical use are available so far. The main objective of this study was to retrospectively evaluate the clinical efficacy of a highly purified, doubly virus-inactivated FVIII/vWF concentrate with a high content of FVIII/vWF (Fanhdi®). Twenty-two patients wit…

Excessive Bleedingcongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtybiologybusiness.industryRetrospective cohort studyHematologyGeneral Medicinemedicine.diseaseGastroenterologyVirusSurgeryVon Willebrand factorCoagulationhemic and lymphatic diseasesInternal medicinebiology.proteinVon Willebrand diseaseMedicinebusinessAdverse effectDesmopressinGenetics (clinical)medicine.drugHaemophilia
researchProduct

Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER

2010

Excessive bleeding represents a major complication of surgical interventions and its control is especially relevant in patients with Congenital Bleeding Disorders (CBD). In factor VII (FVII) deficiency, scanty data on surgery is available to guide treatment strategies. The STER (Seven Treatment Evaluation Registry) is a multi-centre, prospective, observational, web-based study protocol providing the frame for a structured and detailed data collection. Inhibitor occurrence was checked in a centralized fashion. Forty-one surgical operations (24 'major' and 17 'minor') were performed in 34 subjects with a carefully characterized FVII deficiency under the coverage of recombinant activated Facto…

Excessive Bleedingmedicine.medical_specialtyHematologyFactor VIIbusiness.industrymedicine.medical_treatmentHematologymedicine.diseaseSurgerychemistry.chemical_compoundDental extractionchemistryInternal medicineHemostasisOrthopedic surgerymedicineCoagulopathyProspective cohort studybusinessBritish Journal of Haematology
researchProduct

Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia?

2020

Introduction Certain haemophilia carriers demonstrate an increased bleeding tendency, mainly related to clotting factor deficiency. No study has so far formally compared the bleeding phenotype of women and girls with mild FVIII or FIX deficiency and associated management with that of male patients affected by mild haemophilia A and B. Material and methods We retrospectively evaluated 44 women and girls with mild FVIII or FIX deficiency (FVIII or FIX 0.05-0.5 IU/mL) and 77 male patients with mild haemophilia A or B and compared them with respect to clotting factor level, age at and trigger for diagnosis, as well as treatment modalities. Results After excluding gender-related haemorrhagic sym…

FVIIImild haemophiliaAdultMalePediatricsmedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesHeterozygoteAdolescentMucocutaneous zonecarriersPlasma factorAge at diagnosis030204 cardiovascular system & hematologyHaemophiliaHemophilia AHemostatics03 medical and health sciencesYoung Adult0302 clinical medicinecarrierhemic and lymphatic diseasesmedicineHumansDeamino Arginine VasopressinClotting factor deficiencyChildGenetics (clinical)AgedClotting factorAged 80 and overbusiness.industryFIXHematologyGeneral MedicineMiddle Agedmedicine.diseaseBlood Coagulation Factorsbleeding phenotypebleeding phenotype carriers FIX FVIII mild haemophiliaMale patientChild PreschoolMild haemophilia AFemalebusiness030215 immunologyHaemophilia : the official journal of the World Federation of HemophiliaREFERENCES
researchProduct

Electronic Design for a Bleeding Detector to be Used in Intraoperative Radiotherapy Applications

2021

An electronic design for a bleeding detector used with mobile linac during intraoperative radiotherapy (IORT) is presented. It consists on a readout circuit based on a De Sauty Bridge and a wireless power supply using a supercapacitor. The goal is the measurement of the height of fluid present in the applicator in order to avoid a misadministration dose during the irradiation process. A minimum measurement height of 5 mm is required by clinic to be confident with the selected radiation dose. The measurement circuit uses a capacitive sensor which detects variations lower than 0.1 pF. The readout circuit converts dynamic capacitance variation from the bleeding detector into an analog voltage …

FluidsMaterials scienceIntraoperative radiotherapybleeding detectorCapacitive sensingDetectorDe Sauty bridgecapacitive sensorLinearityCapacitive sensorsDetectorsRepeatabilityApplicatorsmobile linacsCapacitanceSignalLinear particle acceleratorBridge circuitswireless supplyElectrical and Electronic EngineeringHemorrhagingInstrumentationVoltageBiomedical engineering
researchProduct

Relationship between upper gastrointestinal bleeding and non steroidal anti-inflammatory

1997

Abstract The authors evaluated the relationship between drug intake and upper gastrointestinal (GI) bleeding. The endoscopic files of the previous 2 years were reviewed and the incidence and age and sex distribution recorded. GI bleeding is indication for a high percentage of lower endoscopies and a low percentage of upper endoscopies. On the other hand, although rarer upper GI bleeding is more severe and frequently related to drug ingestion. About 50% of cases showed gastric erosions secondary to drug intake. A relation between gastric bleeding and paracetamol is considered, as is the possibility of preventing secondary severe bleeding by pharmacologic gastric protection in children with r…

GASTROINTESTINAL BLEEDING NON STEROIDEAL DRUGS
researchProduct

Prophylaxis In Congenital Factor VII Deficiency, Indications, Efficacy and Safety: Results of the STER

2010

Abstract Abstract 665 Introduction Prophylaxis is considered a difficult endeavour in FVII deficiency, especially because of the very short FVII zymogen and FVIIa half-lives, mainly in childhood. The Seven Treatment Evaluation Registry (STER, www.targetseven.org) is a prospective observational, multi-centre, web-based registry concerned with the evaluation of treatments for spontaneous bleeding episodes, surgery and prophylaxis in patients with FVII deficiency. As regards prophylaxis, STER provides the frame for a structured and detailed data capture aiming at: a) identifying patients in whom prophylaxis is advisable, b) defining clinical settings in which prophylaxis is necessary and c) de…

Gastrointestinal bleedingPediatricsmedicine.medical_specialtybusiness.industryImmunologyCell BiologyHematologyHemarthrosismedicine.diseaseBiochemistryRegimenConcomitantSeverity of illnessmedicineProphylaxis in Factor VII deficiency inherited Factor VII deficiencyObservational studyDosingFresh frozen plasmabusinessBlood
researchProduct

Prevention of Upper Gastrointestinal Bleeding in Cirrhotic Patients

1987

The prevalence of varices in patients with cirrhosis is stated to be about 50% and the risk of variceal bleeding 40% with mortality ranging from 30% to 60%. Differences may be due to patient selection and diagnostic criteria. The death risk of first bleeding seems to be higher than that of subsequent episodes (Christensen et al. 1981; D’Amico et al. 1986), indicating that the first bleeding episode causes a selection.

Gastrointestinal bleedingmedicine.medical_specialtyVariceal bleedingCirrhosisbusiness.industrymedicine.diseaseGastroenterologyEsophageal varicesInternal medicinemedicinePortal hypertensionIn patientUpper gastrointestinal bleedingbusinessVarices
researchProduct